CDH2 and melanoma: The switch from E‐cadherin to N‐cadherin expression controlled by PTEN/PI3K signaling in melanoma cells allows them to break away from keratinocytes and bind to N‐cadherin‐expressing fibroblasts 36, 37, 38.